Ardelyx | ARDX - Net Income


Ardelyx reported $-969K in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
Ardelyx USD -969K 18.11M Sep/2025
aTyr Pharma USD -25.74M 6.21M Sep/2025
Corcept Therapeutics USD 24.29M 4.62M Dec/2025
Curis USD -11.8M 80K Jun/2024
Sanofi EUR -801M 3.6B Dec/2025
TG Therapeutics USD 390.9M 362.71M Sep/2025
United Therapeutics USD 364.3M 25.6M Dec/2025
Xoma USD -17.24M 33.23M Sep/2024